BioLife Solutions, Inc. (BLFS) FY2026 YTD Q2 Statement of Cash Flows

Statement of Cash Flows

2026-01-01 to 2026-06-30

Swipe to see the full flow
BioLife Solutions, Inc. cash flow reconciliation, Jan 1, 2026 through Jun 30, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net income (loss) → Net cash from operating activities: $5,857,000.00Net income (loss) → Operating adjustments reconciliation: $40,433,000.00Stock-based compensation → Operating adjustments reconciliation: $8,660,000.00Prepaid expenses and other assets → Operating adjustments reconciliation: $2,972,000.00Non-cash lease expense → Operating adjustments reconciliation: $1,661,000.00Accounts payable → Operating adjustments reconciliation: $836,000.00Depreciation → Operating adjustments reconciliation: $785,000.00Amortization of intangible assets → Operating adjustments reconciliation: $723,000.00Other → Operating adjustments reconciliation: $26,000.00Operating adjustments reconciliation → Deferred income tax (benefit) expense: $42,422,000.00Operating adjustments reconciliation → Inventories: $5,436,000.00Operating adjustments reconciliation → Accrued expenses and other current liabilities: $5,155,000.00Operating adjustments reconciliation → Accounts receivable, trade, net: $2,699,000.00Operating adjustments reconciliation → Accretion of available-for-sale investments: $197,000.00Operating adjustments reconciliation → Sales taxes payable: $187,000.00Maturities of available-for-sale securities → investing reconciliation: $28,586,000.00Proceeds from sale of available-for-sale securities → investing reconciliation: $4,690,000.00investing reconciliation → Purchases of available-for-sale securities: $35,355,000.00investing reconciliation → Purchases of property and equipment: $1,210,000.00investing reconciliation → Purchase of intangible assets: $120,000.00Net cash used in financing activities → financing reconciliation: $11,489,000.00Proceeds from exercises of common stock options → financing reconciliation: $193,000.00Other → financing reconciliation: $3,000.00financing reconciliation → Payment of tax withholding on vesting of shares: $6,685,000.00financing reconciliation → Payments on term loans: $5,000,000.00Net cash used in investing activities → investing reconciliation: $3,409,000.00Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations → Cash sources and uses: $33,038,000.00Net cash from operating activities → Cash sources and uses: $5,857,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations: $23,997,000.00Cash sources and uses → Net cash used in investing activities: $3,409,000.00Cash sources and uses → Net cash used in financing activities: $11,489,000.00Net income (loss): $46,290,000.00Net income (loss)+$46.29 MDepreciation: $785,000.00Depreciation & amortization+$785.00 KAmortization of intangible assets: $723,000.00Intangible amortization+$723.00 KStock-based compensation: $8,660,000.00Stock-based compensation+$8.66 MNon-cash lease expense: $1,661,000.00Non-cash lease expense+$1.66 MDeferred income tax (benefit) expense: -$42,422,000.00Deferred income taxes−$42.42 MAccretion of available-for-sale investments: -$197,000.00Investment discount & premium−$197.00 KGain on disposal of assets held for rent, net: $0.00IPR&D expense: $0.00Accounts receivable, trade, net: -$2,699,000.00Accounts receivable−$2.70 MInventories: -$5,436,000.00Inventories−$5.44 MPrepaid expenses and other assets: $2,972,000.00Prepaid & other assets+$2.97 MAccounts payable: $836,000.00Accounts payable+$836.00 KAccrued expenses and other current liabilities: -$5,155,000.00Accrued & other liabilities−$5.16 MSales taxes payable: -$187,000.00Accrued taxes−$187.00 KOther: $26,000.00Other operating liabilities+$26.00 KNet cash from operating activities: $5,857,000.00Operating cash+$5.86 MOperating adjustments reconciliation: $56,096,000.00Proceeds from exercises of common stock options: $193,000.00Stock option exercises+$193.00 KPayments on term loans: -$5,000,000.00Secured debt repaid−$5.00 MPayment of tax withholding on vesting of shares: -$6,685,000.00Stock-award tax withholding−$6.69 MPayments on financed insurance premium: $0.00Other: $3,000.00Other financing, net+$3.00 KNet cash used in financing activities: -$11,489,000.00. Cash required to fund net payments.Financing cash−$11.49 Mfinancing reconciliation: $11,685,000.00Purchases of available-for-sale securities: -$35,355,000.00AFS securities purchases−$35.36 MProceeds from sale of available-for-sale securities: $4,690,000.00AFS securities sales+$4.69 MMaturities of available-for-sale securities: $28,586,000.00AFS securities maturities+$28.59 MPurchases of assets held for rent: $0.00Purchases of property and equipment: -$1,210,000.00PP&E purchases−$1.21 MInvestment in IPR&D: $0.00Purchase of intangible assets: -$120,000.00Intangible asset purchases−$120.00 KNet cash used in investing activities: -$3,409,000.00. Cash required to fund net payments.Investing cash−$3.41 Minvesting reconciliation: $36,685,000.00Cash sources and uses: $38,895,000.00Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations: $33,038,000.00Beginning cash$33.04 MEnding cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations: $23,997,000.00Ending cash$24.00 MCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flow$4.65 MOperating cash − cash spent on PP&ECash flow / Net income0.13×Operating cash flow ÷ net incomeNet cash change−$9.04 MEnding cash − beginning cash
Chart details

BioLife Solutions, Inc. cash flow reconciliation, Jan 1, 2026 through Jun 30, 2026

Cash flows for Jan 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations. Beginning cash: Dec 31, 2025. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Dec 31, 2025
33,038,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations
Operating activities
5,857,000 US dollars. Net cash provided.
Net income (loss)
46,290,000 US dollars
Depreciation
785,000 US dollars
Amortization of intangible assets
723,000 US dollars
Stock-based compensation
8,660,000 US dollars
Non-cash lease expense
1,661,000 US dollars
Deferred income tax (benefit) expense
negative 42,422,000 US dollars
Accretion of available-for-sale investments
negative 197,000 US dollars
Gain on disposal of assets held for rent, net
0 US dollars
IPR&D expense
0 US dollars
Accounts receivable, trade, net
negative 2,699,000 US dollars
Inventories
negative 5,436,000 US dollars
Prepaid expenses and other assets
2,972,000 US dollars
Accounts payable
836,000 US dollars
Accrued expenses and other current liabilities
negative 5,155,000 US dollars
Sales taxes payable
negative 187,000 US dollars
Other
26,000 US dollars
Investing activities
negative 3,409,000 US dollars. Net cash used.
Purchases of available-for-sale securities
negative 35,355,000 US dollars
Proceeds from sale of available-for-sale securities
4,690,000 US dollars
Maturities of available-for-sale securities
28,586,000 US dollars
Purchases of assets held for rent
0 US dollars
Purchases of property and equipment
negative 1,210,000 US dollars
Investment in IPR&D
0 US dollars
Purchase of intangible assets
negative 120,000 US dollars
Financing activities
negative 11,489,000 US dollars. Net cash used.
Proceeds from exercises of common stock options
193,000 US dollars
Payments on term loans
negative 5,000,000 US dollars
Payment of tax withholding on vesting of shares
negative 6,685,000 US dollars
Payments on financed insurance premium
0 US dollars
Other
3,000 US dollars
Operating adjustment reconciliation
56,096,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
11,685,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
36,685,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
0 US dollars
Ending cash on Jun 30, 2026
23,997,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations
Cash sources and uses
38,895,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
negative 9,041,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
0.13×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
5,857,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
1,210,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
4,647,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income exceeds operating cash. The diagram allocates $5.86M of net income directly to operating cash and $40.43M to the adjustment junction, where it combines with other additions to reconcile deductions. This is an accounting presentation, not a tracing of cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 5,857,000 US dollars minus 1,210,000 US dollars equals 4,647,000 US dollars.
BioLife Solutions, Inc. (BLFS) FY2026 YTD Q2 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!